Benjamin Burnett
Stock Analyst at Wells Fargo
(2.04)
# 3,323
Out of 4,690 analysts
415
Total ratings
42.3%
Success rate
0.4%
Average return
Main Sectors:
Stocks Rated by Benjamin Burnett
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RARE Ultragenyx Pharmaceutical | Rated: Buy | $46 → $50 | $25.61 | +95.24% | 10 | Aug 28, 2026 | |
| UTHR United Therapeutics | Maintained: Buy | $700 | $515.46 | +35.80% | 11 | Aug 19, 2026 | |
| LQDA Liquidia | Maintained: Buy | $108 | $67.69 | +59.55% | 8 | Aug 19, 2026 | |
| PTCT PTC Therapeutics | Rated: Buy | $106 → $109 | $70.09 | +55.51% | 8 | Aug 13, 2026 | |
| DFTX Definium Therapeutics | Reiterated: Buy | $68 → $72 | $40.98 | +75.70% | 2 | Aug 13, 2026 | |
| AXSM Axsome Therapeutics | Maintained: Buy | $255 → $256 | $199.02 | +28.63% | 8 | Aug 11, 2026 | |
| SVRA Savara | Rated: Buy | $9 | $5.26 | +71.10% | 6 | Aug 11, 2026 | |
| AMPH Amphastar Pharmaceuticals | Rated: Hold | $19 → $20 | $22.01 | -9.13% | 2 | Aug 7, 2026 | |
| TECX Tectonic Therapeutic | Maintained: Buy | $101 → $93 | $35.62 | +161.09% | 4 | Aug 7, 2026 | |
| PRAX Praxis Precision Medicines | Maintained: Hold | $323 → $362 | $344.75 | +5.00% | 7 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $161 → $169 | $118.54 | +42.57% | 9 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $14 → $13 | $3.95 | +229.11% | 8 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $13 | $13.73 | -5.32% | 2 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 → $18 | $11.03 | +63.19% | 5 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $5.04 | +177.78% | 8 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $65 | $47.41 | +37.10% | 12 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $12.18 | +31.36% | 1 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $44 | $27.94 | +57.48% | 1 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $69 | $59.99 | +15.02% | 10 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $46 | $48.77 | -5.68% | 3 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $78 → $64 | $207.88 | n/a | 19 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 → $13 | $3.12 | n/a | 8 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $6.95 | n/a | 19 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $8.01 | n/a | 33 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4.5 → $4 | $2.02 | n/a | 23 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 → $3 | $9.20 | n/a | 30 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 → $3 | $2.43 | n/a | 23 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $94 → $92 | $80.03 | n/a | 21 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 | $0.6997 | n/a | 7 | Mar 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $53 → $49 | $57.72 | n/a | 23 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $66 → $64 | $40.11 | n/a | 20 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $0.0003 | n/a | 15 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $42 | $7.78 | n/a | 11 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3.9 → $3.6 | $0.1605 | n/a | 12 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4.7 → $3 | $72.52 | n/a | 12 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4.5 | $36.58 | n/a | 3 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4.7 → $0.16 | $0.000001 | n/a | 9 | Apr 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $84 → $120 | $29.32 | n/a | 2 | Feb 28, 2022 |
Ultragenyx Pharmaceutical
Aug 28, 2026
Rated: Buy
Price Target: $46 → $50
Current: $25.61
Upside: +95.24%
United Therapeutics
Aug 19, 2026
Maintained: Buy
Price Target: $700
Current: $515.46
Upside: +35.80%
Liquidia
Aug 19, 2026
Maintained: Buy
Price Target: $108
Current: $67.69
Upside: +59.55%
PTC Therapeutics
Aug 13, 2026
Rated: Buy
Price Target: $106 → $109
Current: $70.09
Upside: +55.51%
Definium Therapeutics
Aug 13, 2026
Reiterated: Buy
Price Target: $68 → $72
Current: $40.98
Upside: +75.70%
Axsome Therapeutics
Aug 11, 2026
Maintained: Buy
Price Target: $255 → $256
Current: $199.02
Upside: +28.63%
Savara
Aug 11, 2026
Rated: Buy
Price Target: $9
Current: $5.26
Upside: +71.10%
Amphastar Pharmaceuticals
Aug 7, 2026
Rated: Hold
Price Target: $19 → $20
Current: $22.01
Upside: -9.13%
Tectonic Therapeutic
Aug 7, 2026
Maintained: Buy
Price Target: $101 → $93
Current: $35.62
Upside: +161.09%
Praxis Precision Medicines
Aug 7, 2026
Maintained: Hold
Price Target: $323 → $362
Current: $344.75
Upside: +5.00%
Aug 6, 2026
Maintained: Buy
Price Target: $161 → $169
Current: $118.54
Upside: +42.57%
Aug 5, 2026
Rated: Buy
Price Target: $14 → $13
Current: $3.95
Upside: +229.11%
Aug 5, 2026
Maintained: Hold
Price Target: $13
Current: $13.73
Upside: -5.32%
Aug 3, 2026
Rated: Buy
Price Target: $20 → $18
Current: $11.03
Upside: +63.19%
Jul 30, 2026
Maintained: Buy
Price Target: $14
Current: $5.04
Upside: +177.78%
Jul 29, 2026
Rated: Buy
Price Target: $65
Current: $47.41
Upside: +37.10%
Jul 27, 2026
Initiated Coverage: Buy
Price Target: $16
Current: $12.18
Upside: +31.36%
Jul 27, 2026
Initiated Coverage: Buy
Price Target: $44
Current: $27.94
Upside: +57.48%
Jun 1, 2026
Maintained: Buy
Price Target: $69
Current: $59.99
Upside: +15.02%
Apr 22, 2026
Maintained: Buy
Price Target: $46
Current: $48.77
Upside: -5.68%
Apr 1, 2025
Maintained: Buy
Price Target: $78 → $64
Current: $207.88
Upside: n/a
Mar 31, 2025
Maintained: Buy
Price Target: $26 → $13
Current: $3.12
Upside: n/a
Mar 20, 2025
Reiterated: Buy
Price Target: $7
Current: $6.95
Upside: n/a
Mar 17, 2025
Maintained: Buy
Price Target: $18
Current: $8.01
Upside: n/a
Mar 17, 2025
Maintained: Hold
Price Target: $4.5 → $4
Current: $2.02
Upside: n/a
Mar 11, 2025
Maintained: Hold
Price Target: $5 → $3
Current: $9.20
Upside: n/a
Mar 6, 2025
Maintained: Hold
Price Target: $5 → $3
Current: $2.43
Upside: n/a
Mar 3, 2025
Maintained: Buy
Price Target: $94 → $92
Current: $80.03
Upside: n/a
Mar 2, 2025
Maintained: Buy
Price Target: $80
Current: $0.6997
Upside: n/a
Feb 13, 2025
Maintained: Hold
Price Target: $53 → $49
Current: $57.72
Upside: n/a
Nov 6, 2024
Maintained: Buy
Price Target: $66 → $64
Current: $40.11
Upside: n/a
Apr 19, 2024
Maintained: Buy
Price Target: $10
Current: $0.0003
Upside: n/a
Aug 16, 2023
Maintained: Buy
Price Target: $42
Current: $7.78
Upside: n/a
Aug 10, 2023
Maintained: Hold
Price Target: $3.9 → $3.6
Current: $0.1605
Upside: n/a
Mar 2, 2023
Maintained: Hold
Price Target: $4.7 → $3
Current: $72.52
Upside: n/a
Nov 15, 2022
Downgraded: Hold
Price Target: $4.5
Current: $36.58
Upside: n/a
Apr 29, 2022
Downgraded: Hold
Price Target: $4.7 → $0.16
Current: $0.000001
Upside: n/a
Feb 28, 2022
Reiterated: Buy
Price Target: $84 → $120
Current: $29.32
Upside: n/a